New treatment option for Depression
Official title Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression
ClinicalTrials.gov ID: NCT06384196
What this study is testing
- What it's testing
- Depression and anxiety are the most prevalent mental disorders among both the general population and young adults, and transdiagnostic treatments for these patients are mostly based on cognitive-behavioral therapy (CBT). Based on common (transdiagnostic) principles of treatment (e.g., emotional exposure), these approaches have proliferated and demonstrated their efficacy in comparison to disorder-specific treatments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 29
You may be able to join if
- Participants with symptoms of depression and/or anxiety as their primary complaint.
You likely can't join if
- Participants with post-traumatic stress, bipolar and substance use disorders, psychotic symptoms, organic brain dysfunction, marked suicidal ideation...
- Participants receiving psychological treatment, unless it is suspended at the time of inclusion in the study itself in agreement with their therapist.
- Participants for whom the use of virtual reality may pose a risk, even a minor risk (epilepsia, acute otorhinolaryngological processes or recent...
- Participants with substantial visual, hearing, and cognitive deficits.
- Participants who do not have enough competence to communicate in Spanish or Catalan.
The study team makes the final eligibility decision.
Where it's taking place
- Badalona, Spain
- Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 29 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Badalona, Spain; Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.